Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
NOVEL METHOD FOR THE PREPARATION OF DERIVATIVES OF DIHYDROTETRAAZAPENTACENES, PRODUCTS SUCH AS OBTAINED, AND USES THEREOF
Document Type and Number:
WIPO Patent Application WO/2009/083532
Kind Code:
A3
Abstract:
The present invention relates to a method for the preparation of compounds having the following formula (I) in which: R1, R2, R3, and R4 represent, independently from each other, in particular H or an alkyl group having from 1 to 20 carbon atoms, said method comprising the reaction of a compound of formula (II) R1 and R2 being as defined above, with a compound having the following formula (III): R3 and R4 being as defined above, in the presence of a catalytic amount of an acid.

Inventors:
SIRI OLIVIER (FR)
SEILLAN CLAIRE (FR)
Application Number:
PCT/EP2008/068160
Publication Date:
November 12, 2009
Filing Date:
December 22, 2008
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
UNIV AIX MARSEILLE II (FR)
CENTRE NAT RECH SCIENT (FR)
SIRI OLIVIER (FR)
SEILLAN CLAIRE (FR)
International Classes:
C07D487/04; A61K31/495; C07D241/44; C09B5/24
Domestic Patent References:
WO2007066098A12007-06-14
WO1994029314A11994-12-22
Foreign References:
GB988331A1965-04-07
Other References:
E. ASMUS, J. PETERS: "Photometrische Bestimmung von Titan in molybdänhaltigen Stählen mit Tetrahydroxyphenazin", Z. ANAL. CHEM., vol. 249, 1970, pages 106 - 109, XP002488331
Attorney, Agent or Firm:
BLOT, Philippe et al. (Paris Cedex 09, FR)
Download PDF:
Claims:
CLAIMS

1. A method for the preparation of compounds having the following formula (I):

in which: Ri, R 2 , R3, and R 4 represent, independently from each other, a substituent selected from the group consisting of: . H

. alkyl group having from 1 to 20, and preferably from 1 to 10, carbon atoms, . alkenyl group having from 1 to 6 carbon atoms,

. alkynyl group having from 1 to 6 carbon atoms,

. aryl or heteroaryl group having 6 to 30, and preferably from 6 to 10, carbon atoms,

. (C 6 -Cio)aryl(Ci-C 4 )alkyl group, . acyl group having from 1 to 20 carbon atoms, in particular CO-R group, wherein R is H, an alkyl group, an alkenyl group, an alkynyl group, or an aryl group, as defined above,

. NR'R", wherein R' and R" represent, independently from each other, H, an alkyl group, an alkenyl group, an alkynyl group, or an aryl group, as defined above,

. CONR'R", wherein R' and R" are as defined above, . NHCOR, wherein R is as defined above, . COOR, wherein R is as defined above, . OCOR, wherein R is as defined above, . OR, wherein R is as defined above,

. SR, wherein R is as defined above, . SO 2 R, wherein R is as defined above, . SO 2 NR 1 R", wherein R' and R" are as defined above,

. SO 3 H,

. halogen such as Cl, F, Br or I,

- CF 3 ,

. CN, and

. nitro, or salts thereof, said method comprising the reaction of a compound of formula

Ri and R 2 being as defined above,

with a compound having the following formula (III):

R 3 and R 4 being as defined above,

in the presence of a catalytic amount of an acid selected from the group consisting of: acetic acid, trifluoroacetic acid, and diluted hydrochloric acid.

2. The method of claim 1 , wherein the compound of formula (II) is obtained by the reaction of 2,5-dihydroxy-1 ,4-benzoquinone with a compound having the following formula (IV):

Ri and R 2 being as defined in claim 1 , said reaction being carried out in water or ethanol, or mixtures thereof.

3. A method for the preparation of compounds having the following formula (I):

in which:

Ri, R 2 , R 3 , and R 4 represent, independently from each other, a substituent selected from the group consisting of:

. H . alkyl group having from 1 to 20, and preferably from 1 to 10, carbon atoms,

. alkenyl group having from 1 to 6 carbon atoms, . alkynyl group having from 1 to 6 carbon atoms,

. aryl or heteroaryl group having 6 to 30, and preferably from 6 to 10, carbon atoms,

. (C 6 -Cio)aryl(Ci-C 4 )alkyl group,

. acyl group having from 1 to 20 carbon atoms, in particular CO-R group, wherein R is H, an alkyl group, an alkenyl group, an alkynyl group, or an aryl group, as defined above, . NR'R", wherein R' and R" represent, independently from each other,

H, an alkyl group, an alkenyl group, an alkynyl group, or an aryl group, as defined above,

. CONR'R", wherein R' and R" are as defined above, . NHCOR, wherein R is as defined above, . COOR, wherein R is as defined above,

. OCOR, wherein R is as defined above, . OR, wherein R is as defined above, . SR, wherein R is as defined above, . SO 2 R, wherein R is as defined above, . SO2NR'R", wherein R' and R" are as defined above,

. SO 3 H,

. halogen such as Cl, F, Br or I, - CF 3 ,

. CN, and . nitro, or salts thereof, said method comprising: a) the reaction of 2,5-dihydroxy-1 ,4-benzoquinone with a compound having the following formula (IV):

Ri and R2 being as defined in claim 1 , said reaction being carried out in water or ethanol, or mixtures thereof, to obtain a compound of formula (II) as follows:

Ri and R2 being as defined above, said compound of formula (II) being then isolated, b) and the reaction of said compound of formula (II) with a compound having the following formula

R 3 and R 4 being as defined above, in the presence of a catalytic amount of an acid selected from the group consisting of: acetic acid, trifluoroacetic acid, and diluted hydrochloric acid, to obtain said compound of formula (I).

4. A compound having the following formula (I):

in which:

Ri , R 2 , R3, and R 4 represent, independently from each other, a substituent selected from the group consisting of:

. H

. alkyl group having from 1 to 20, and preferably from 1 to 10, carbon atoms,

. alkenyl group having from 1 to 6 carbon atoms,

. alkynyl group having from 1 to 6 carbon atoms,

. aryl or heteroaryl group having 6 to 30, and preferably from 6 to 10, carbon atoms, . (C 6 -Cio)aryl(Ci-C 4 )alkyl group,

. acyl group having from 1 to 20 carbon atoms, in particular CO-R group, wherein R is H, an alkyl group, an alkenyl group, an alkynyl group, or an aryl group, as defined above,

. NR'R", wherein R' and R" represent, independently from each other, H, an alkyl group, an alkenyl grou, an alkynyl group, or an aryl group, as defined above,

. CONR'R", wherein R' and R" are as defined above,

. NHCOR, wherein R is as defined above,

. COOR, wherein R is as defined above, . OCOR, wherein R is as defined above,

. OR, wherein R is as defined above,

. SR, wherein R is as defined above,

. SO 2 R, wherein R is as defined above,

. SO 2 NR 1 R", wherein R' and R" are as defined above, . SO 3 H,

. halogen such as Cl, F, Br or I,

. CF 3 ,

. CN, and

. nitro, or salts thereof.

5. The compound of claim 4, wherein Ri and R 2 are H.

6. The compound of any of claims 4 or 5, wherein Ri and R2 are alkyl groups such as defined in claim 4, and in particular methyl groups.

7. The compound of any of claims 4 to 6, wherein R 4 is COOR, R being as defined in claim 4, and being preferably H.

8. The compound of any of claims 4 to 6, wherein R 4 is a halogen atom, in particular Cl.

9. An intermediate compound having the following formula (II):

in which: Ri, and R 2 represent, independently from each other, a substituent selected from the group consisting of: . H

. alkyl group having from 1 to 20, and preferably from 1 to 10, carbon atoms, . alkenyl group having from 1 to 6 carbon atoms,

. alkynyl group having from 1 to 6 carbon atoms,

. aryl or heteroaryl group having 6 to 30, and preferably from 6 to 10, carbon atoms,

. (C 6 -Cio)aryl(Ci-C 4 )alkyl group, . acyl group having from 1 to 20 carbon atoms, in particular CO-R group, wherein R is H, an alkyl group, an alkenyl group, an alkynyl group, or an aryl group, as defined above,

. NR 1 R", wherein R' and R" represent, independently from each other, H, an alkyl group, an alkenyl group, an alkynyl group, or an aryl group, as defined above,

. CONR'R", wherein R' and R" are as defined above, . NHCOR, wherein R is as defined above, . COOR, wherein R is as defined above,

. OCOR, wherein R is as defined above,

. OR, wherein R is as defined above,

. SR, wherein R is as defined above,

. SO 2 R, wherein R is as defined above, . SO 2 NR 1 R", wherein R' and R" are as defined above,

. SO 3 H,

. halogen such as Cl, F, Br or I,

- CF 3 ,

. CN, and . nitro, with the proviso that when Ri is H, then R 2 is not H, and that when R 2 is

H, then Ri is not H, and with the proviso that when Ri is OH, then R 2 is not OH, and that when

R 2 is OH, then R 1 is not OH.

10. The use of a compound of any of claims 4 to 8, as a chromophore or as a semi-conductive material.

11. The use of a compound of claim 4, wherein at least one of Ri, R 2 , R 3 , and R 4 groups is COOH, as a light-emitting molecule.

12. The use of a compound of any of claims 4 to 8, as a dye or pigment.

13. A cosmetic composition comprising a compound of any of claims 4 to 8, in association with a cosmetically acceptable vehicle.

14. A method for the cosmetic treatment, comprising the administration of a compound of any of claims 4 to 8, or of the cosmetic composition of claim 13.

Description:

NOVEL METHOD FOR THE PREPARATION OF DERIVATIVES OF DIHYDROTETRAAZAPENTACENES, PRODUCTS SUCH AS OBTAINED, AND USES THEREOF

The present invention concerns a novel method for the preparation of derivatives of dihydrotetraazapentacenes, and derivatives of dihydrotetraazapentacenes as obtained by said method.

The present invention also concerns the use of said derivatives of dihydrotetraazapentacenes, in particular, as dyes, pigments, or chromophores.

Molecules exhibiting an extended conjugated pi system such as oligoacenes have attracted considerable interests for decades owing to their remarkable properties for electronic plastic and photonic devices (V. Coropceanu, J. Cornil, D. A. d. S. Filho, Y. Olivier, R. Silbey, J. -L. Bredas,

Chem. Rev. 2007, 107, 926; A. R. Murphy, J. M. J. Frechet, Chem. Rev. 2007, 107, 1066; J. G. C. Veinot, T. J. Marks, Ace. Chem. Res. 2005, 38, 632; and S. Gϋnes, H. Neugebauer, N. S. Sariciftci, Chem. Rev. 2007, 107, 1324). Recent theoretical studies (M. Winkler, K. N. Houk, J. Am. Chem. Soc. 2007, 129, 1805) suggested the use of polyazaacenes since the successive replacement of CH moieties by nitrogen atoms in oligoacenes offers number of opportunity to manipulate and control the electronic properties, the stability and the crystal structure in the solid state. Such compounds are very attractive for electronic applications such as organic thin-film transistors (OTFTs)(Y. Ma, Y. Sun, Y. Liu, J. Gao, S. Chen, X. Sun, W. Qiu, G. Yu, G.

Cui, W. Hu, D. Zhu, J. Mater. Chem. 2005, 15, 4894), organic light emitting diodes (OLEDs) (M. B. Casu, P. Imperia, S. Schrader, B. FaIk, Surface Science 2001 , 482-485, 1205; M. B. Casu, P. Imperia, S. Schrader, B. FaIk, M. Jandke, P. Strohriegl, Synthetic Metals 2001 , 124, 79) and photovoltaic cells (M. Antinucci, B. Chevalier, A. Ferriolo, Solar Energy Materials and

Solar Cells 1995, 39, 271 ), owing to the presence of heterocyclic rings that are responsible for a high ionisation potential, high electron affinity, and a better stability.

Only few examples of substituted dihydrotetraazapentacenes (DHTAP) are reported in the literature. In particular, N- and C-substituted systems (O. Fischer, E. Hepp, Chem. Ber. 1890, 23, 1789; O. Fischer, E. Hepp, 1895, 28, 293; O. N. Witt, Chem. Ber. 1887, 20, 1538; M. A. Hassan, R. F. Fandy, T. M. El-Amine, J. Heterocyclic Chem. 2001 , 38, 179) were prepared but not used for electronic applications. In particular, WO2007/066098 describes a one-pot procedure which limits the control of the condensation owing to the presence of a mixture of four reagents and which requires the need of a large amount of acid, and WO 94/29314 discloses a two steps preparation in oxidizing medium (via the diaminophenazine intermediate) for which tuning the four terminal substituents is not possible.

An aim of the present invention is to provide a method for preparing derivatives of dihydrotetraazapentacenes, which is more versatile and more ecological than the prior art methods. An aim of the present invention is also to provide a method for the preparation of a plurality of substituted derivatives, wherein the number and the nature of said substituents can be controlled.

An aim of the present invention is also to provide a method for preparing various derivatives of dihydrotetraazapentacenes, said derivatives containing a plurality of various substituents.

An aim of the invention is also to provide new derivatives of dihydrotetraazapentacenes, and in particular dissymmetrical derivatives.

The present invention relates to a method for the preparation of compounds having the following formula (I):

in which: Ri, R 2 , R3, and R 4 represent, independently from each other, a substituent selected from the group consisting of: . H

. alkyl group having from 1 to 20, and preferably from 1 to 10, carbon atoms,

. alkenyl group having from 1 to 6 carbon atoms, . alkynyl group having from 1 to 6 carbon atoms, . aryl or heteroaryl group having 6 to 30, and preferably from 6 to 10, carbon atoms,

. (C 6 -Cio)aryl(Ci-C 4 )alkyl group, . acyl group having from 1 to 20 carbon atoms, in particular CO-R group, wherein R is H, an alkyl group, an alkenyl group, an alkynyl group, or an aryl group, as defined above,

. NR'R", wherein R' and R" represent, independently from each other,

H, an alkyl group, an alkenyl group, an alkynyl group, or an aryl group, as defined above,

. CONR'R", wherein R' and R" are as defined above, . NHCOR, wherein R is as defined above,

. COOR, wherein R is as defined above, . OCOR, wherein R is as defined above, . OR, wherein R is as defined above, . SR, wherein R is as defined above, . SO2R, wherein R is as defined above,

. SO 2 NR 1 R", wherein R' and R" are as defined above, . SO 3 H,

. halogen such as Cl, F, Br or I, . CF 3 , . CN, and

. nitro, or salts thereof, said method comprising the reaction of a compound of formula (II)

Ri and R 2 being as defined above,

with a compound having the following formula (III):

R 3 and R 4 being as defined above, in the presence of a catalytic amount of an acid selected from the group consisting of: acetic acid, trifluoroacetic acid, and diluted hydrochloric acid.

The reaction of a compound of formula (II) with a compound of formula (III) is thus carried out without any solvent. The above-mentioned catalytic amount of acid is preferably comprised from 0.1 ml_ to 5 ml_, and in particular from 0.5 to 1 ml_, for 1 mmol of compound of formula (II), and most preferably said catalytic amount is 1 ml_ for 1 mmol of compound of formula (II).

As used herein, the term "alkyl" refers to a hydrocarbon chain that may be a straight chain or branched chain, containing the indicated number of carbon atoms. For example, C1-C12 alkyl indicates that the group may have from 1 to 12 (inclusive) carbon atoms in it. Said alkyl groups can be methyl, ethyl, propyl, isopropyl, butyl, isobutyl, sec-butyl, tert-butyl, pentyl, isoamyl, neopentyl, 1 -ethyl propyl, 3-methylpentyl, 2,2-dimethylbutyl, 2,3-dimethylbutyl, or hexyl.

Said alkyl group can also be a cycloalkyl group. The term "cycloalkyl" as employed herein includes saturated cyclic, bicyclic, tricyclic, or polycyclic hydrocarbon groups having 3 to 12 carbons, wherein any ring atom capable of substitution can be substituted by a substituent. Examples of cycloalkyl moieties include, but are not limited to, cyclohexyl and adamantyl.

The term "substituents" refers to a group "substituted" on an alkyl, alkenyl, alkynyl, cycloalkyl, aryl, or heteroaryl group at any atom of that group. Suitable substituents include, without limitation, alkyl, alkenyl, alkynyl, alkoxy, halo, hydroxy, cyano, nitro, amino, SO 3 H, sulfate, phosphate, perfluoroalkyl, perfluoroalkoxy, methylenedioxy, ethylenedioxy, carboxyl, oxo, thioxo, imino (alkyl, aryl, aralkyl), S(O) n alkyl (where n is 0-2), S(O) n aryl (where n is 0-2), S(O) n heteroaryl (where n is 0-2), S(O) n heterocyclyl (where n is 0- 2), amine (mono-, di-, alkyl, cycloalkyl, aralkyl, heteroaralkyl, and

combinations thereof), ester (alkyl, aralkyl, heteroaralkyl), amide (mono-, di-, alkyl, aralkyl, heteroaralkyl, and combinations thereof), sulfonamide (mono-, di-, alkyl, aralkyl, heteroaralkyl, and combinations thereof), unsubstituted aryl, unsubstituted heteroaryl, unsubstituted heterocyclyl, and unsubstituted cycloalkyl.

As used herein, the term "alkenyl" refers to a nonaromatic hydrocarbon chain that may be a straight chain or branched chain, containing at least one carbon-carbon double bond, and having the indicated number of carbon atoms. This term also includes the cycloalkenyl and heterocycloalkenyl groups.

The term "cycloalkenyl" as employed herein includes partially unsaturated, nonaromatic, cyclic, bicyclic, tricyclic, or polycyclic hydrocarbon groups having 5 to 12 carbons, preferably 5 to 8 carbons, wherein any ring atom capable of substitution can be substituted by a substituent. Examples of cycloalkyl moieties include, but are not limited to cyclohexenyl, cyclohexadienyl, or norbornenyl.

The term "heterocycloalkenyl" refers to a partially saturated, nonaromatic 5- 10 membered monocyclic, 8-12 membered bicyclic, or 11-14 membered tricyclic ring system having 1 -3 heteroatoms if monocyclic, 1-6 heteroatoms if bicyclic, or 1 -9 heteroatoms if tricyclic, said heteroatoms selected from O, N, or

S (e.g., carbon atoms and 1 -3, 1-6, or 1 -9 heteroatoms of N, O, or S if monocyclic, bicyclic, or tricyclic, respectively), wherein any ring atom capable of substitution can be substituted by a substituent.

As used herein, the term "alkynyl" refers to a nonaromatic hydrocarbon chain that may be a straight chain or branched chain, containing at least one carbon-carbon triple bond, and having the indicated number of carbon atoms.

The term "acyl" refers to an alkylcarbonyl, cycloalkylcarbonyl, arylcarbonyl, heterocyclylcarbonyl, or heteroarylcarbonyl substituent, any of which may be further substituted by substituents. The term "aryl" refers to an aromatic monocyclic, bicyclic, or tricyclic hydrocarbon ring system, wherein any ring atom capable of substitution can be substituted by a substituent. Examples of aryl moieties include, but are not limited to, phenyl, naphthyl, and anthracenyl.

As used herein, the term "arylalkyl" refers to an alkyl group that is substituted with an aryl group, wherein the alkyl and aryl groups are as defined above. Examples of arylalkyl groups include, but are not limited to, benzyl, bromobenzyl, phenethyl, benzhydryl, diphenylmethyl, thphenylmethyl, diphenylethyl, naphthylmethyl, and 9-fluorenyl groups etc.

The term "heterocyclyl" refers to a nonaromatic 3-10 membered monocyclic, 8-12 membered bicyclic, or 11-14 membered tricyclic ring system having 1 -3 heteroatoms if monocyclic, 1 -6 heteroatoms if bicyclic, or 1 -9 heteroatoms if tricyclic, said heteroatoms selected from O, N, or S (e. g. , carbon atoms and 1 -3, 1 -6, or1 -9 heteroatoms of N, O, or S if monocyclic, bicyclic, or tricyclic, respectively), wherein any ring atom capable of substitution can be substituted by a substituent.

The term "heteroaryl" refers to an aromatic 5-8 membered monocyclic, 8-12 membered bicyclic, or 11-14 membered tricyclic ring system having 1-3 heteroatoms if monocyclic, 1 -6 heteroatoms if bicyclic, or 1 -9 heteroatoms if tricyclic, said heteroatoms selected from O, N, or S (e. g. , carbon atoms and 1 -3, 1 -6, or 1 -9 heteroatoms of N, O, or S if monocyclic, bicyclic, or tricyclic, respectively), wherein any ring atom capable of substitution can be substituted by a substituent. According to a preferred embodiment of the method of the present invention, the compound of formula (II) as mentioned above is obtained by the reaction of 2,5-dihydroxy-1 ,4-benzoquinone with a compound having the following formula (IV):

Ri and R2 being as defined above, said reaction being carried out in water or ethanol, or mixtures thereof. This step is carried out in the presence of non toxic solvents.

The present invention relates to a method for the preparation of compounds having the following formula (I):

in which:

Ri, R 2 , R 3 , and R 4 represent, independently from each other, a substituent selected from the group consisting of: . H

. alkyl group having from 1 to 20, and preferably from 1 to 10, carbon atoms,

. alkenyl group having from 1 to 6 carbon atoms, . alkynyl group having from 1 to 6 carbon atoms, . aryl or heteroaryl group having 6 to 30, and preferably from 6 to 10, carbon atoms,

. (C 6 -Cio)aryl(Ci-C 4 )alkyl group,

. acyl group having from 1 to 20 carbon atoms, in particular CO-R group, wherein R is H, an alkyl group, an alkenyl group, an alkynyl group, or an aryl group, as defined above,

. NR'R", wherein R' and R" represent, independently from each other, H, an alkyl group, an alkenyl group, an alkynyl group, or an aryl group, as defined above,

. CONR'R", wherein R' and R" are as defined above, . NHCOR, wherein R is as defined above,

. COOR, wherein R is as defined above, . OCOR, wherein R is as defined above, . OR, wherein R is as defined above, . SR, wherein R is as defined above, . SO2R, wherein R is as defined above,

. SO 2 NR 1 R", wherein R' and R" are as defined above,

. SO 3 H,

. halogen such as Cl, F, Br or I,

. CF 3 ,

. CN, and

. nitro, or salts thereof, said method comprising: a) the reaction of 2,5-dihydroxy-1 ,4-benzoquinone with a compound having the following formula (IV):

(IV)

Ri and R 2 being as defined above, said reaction being carried out in water or ethanol, or mixtures thereof, to obtain a compound of formula (II) as follows:

Ri and R 2 being as defined above, said compound of formula (II) being then isolated, b) and the reaction of said compound of formula (II) with a compound having the following formula (III):

R 3 and R 4 being as defined above, in the presence of a catalytic amount of an acid selected from the group consisting of: acetic acid, trifluoroacetic acid, and diluted hydrochloric acid, to obtain said compound of formula (I).

The present invention also relates to compounds having the following formula (I):

in which:

Ri , R 2 , R3, and R 4 represent, independently from each other, a substituent selected from the group consisting of:

. H

. alkyl group having from 1 to 20, and preferably from 1 to 10, carbon atoms,

. alkenyl group having from 1 to 6 carbon atoms,

. alkynyl group having from 1 to 6 carbon atoms,

. aryl or heteroaryl group having 6 to 30, and preferably from 6 to 10, carbon atoms, . (C 6 -Cio)aryl(Ci-C 4 )alkyl group,

. acyl group having from 1 to 20 carbon atoms, in particular CO-R group, wherein R is H, an alkyl group, an alkenyl group, an alkynyl group, or an aryl group, as defined above,

. NR'R", wherein R' and R" represent, independently from each other, H, an alkyl group, an alkenyl group, an alkynyl group, or an aryl group, as defined above,

. CONR'R", wherein R' and R" are as defined above,

. NHCOR, wherein R is as defined above,

. COOR, wherein R is as defined above, . OCOR, wherein R is as defined above,

. OR, wherein R is as defined above,

. SR, wherein R is as defined above,

. SO 2 R, wherein R is as defined above,

. SO 2 NR 1 R", wherein R' and R" are as defined above, . SO 3 H,

. halogen such as Cl, F, Br or I,

. CF 3 ,

. CN, and

. nitro, or salts thereof.

The compounds of the invention also include protonated forms of the compounds of formula (I) as mentioned above, which have in particular the following formula:

wherein R 1 , R 2 , R 3 , and R 4 are as defined above, and wherein X is selected from the group consisting of: F 3 COO, Cl, F, Br, I, BF 4 , and H 3 COO.

According to a preferred embodiment, at least one of the Ri, R 2 , R 3 , and R 4 groups of formula (I) is other than H.

Preferably, in formula (I), when one of the Ri, R 2 , R 3 , and R 4 groups is an acid group COOH or SO 3 H, then none of the remaining Ri, R 2 , R 3 , and R 4 groups is an amide group such as CONH 2 , CONR'R", SO 2 NH 2 or SO 2 NR 1 R", R' and R" being as defined above.

Preferably, in the compounds of the present invention, when Ri = R 2 = R 3 = H, then R 4 is not COOH.

According to a particular embodiment, the compounds of the invention have the formula (I), wherein R 1 and R 2 are H.

According to another particular embodiment, the compounds of the invention have the formula (I), wherein R 1 , R 2 and R 3 are H.

More particularly, the present invention relates to a compound of formula (I) wherein R 1 , R 2 and R 3 are H, and R 4 is a halogen atom, in particular Cl. When R 4 is Cl, the compound has the following formula:

More particularly, the present invention also relates to a compound of formula (I) wherein R 1 and R 2 are H, and R 3 and R 4 are halogen atoms, in particular Cl.

When R 3 and R 4 are Cl, the compound has the following formula:

More particularly, the present invention also relates to a compound of formula (I) wherein R 1 , R 2 and R 3 are H, and R 4 is COOR, R being as defined above, and being preferably H. When R 4 is COOH, the compound has the following formula:

More particularly, the present invention also relates to a compound of formula (I) wherein Ri, R 2 and R 3 are H, and R 4 is an alkyl group, and in particular a methyl group.

More particularly, the present invention also relates to a compound of formula (I) wherein R 1 , R 3 and R 4 are H, and R 2 is an alkyl group, and in particular a methyl group. When R 2 is methyl, the compound has the following formula:

According to a particular embodiment, the compounds of the invention have the formula (I), wherein R 1 and R 2 are alkyl groups such as defined above, and in particular methyl groups.

According to another particular embodiment, the compounds of the invention have the formula (I), wherein R 1 and R 2 are alkyl groups, and R 3 is H.

More particularly, the present invention relates to a compound of formula (I) wherein R 1 and R 2 are alkyl groups, and R 3 and R 4 are H.

When Ri and R2 are methyl, the compound has the following formula:

More particularly, the present invention also relates to a compound of formula (I) wherein R 1 and R 2 are alkyl groups, and R 3 is H, and R 4 is COOR, R being as defined above.

When Ri and R 2 are methyl, and R is H, the compound has the following formula:

According to another particular embodiment, the compounds of the invention have the formula (I), wherein R 4 is COOR, R being as defined above, and being preferably H.

According to another particular embodiment, the compounds of the invention have the formula (I), wherein R 4 is a halogen atom, in particular Cl.

Other preferred compounds of the invention are compounds of formula (I) wherein Ri and R 2 are OR, R being as defined above, and being preferably an alkyl group. Among these preferred compounds, the following is particularly referred:

Other preferred compounds of the invention are compounds of formula (I), wherein Ri and R 2 are OR, R being as defined above, and being preferably an alkyl group, and wherein R 4 is COOR. Among these preferred compounds, the following is particularly preferred:

Other preferred compounds of the invention are compounds of formula (I), wherein Ri, R 2 , R3 and R 4 are OR, R being as defined above, and being preferably an alkyl group. Among these preferred compounds, the following is particularly preferred:

The present invention also relates to the intermediate compounds having the following formula (II):

in which:

Ri, and R 2 represent, independently from each other, a substituent selected from the group consisting of: . H . alkyl group having from 1 to 20, and preferably from 1 to 10, carbon atoms,

. alkenyl group having from 1 to 6 carbon atoms, . alkynyl group having from 1 to 6 carbon atoms, . aryl or heteroaryl group having 6 to 30, and preferably from 6 to 10, carbon atoms,

. (C 6 -Cio)aryl(Ci-C 4 )alkyl group, . acyl group having from 1 to 20 carbon atoms, in particular CO-R group, wherein R is H, an alkyl group, an alkenyl group, an alkynyl group, or an aryl group, as defined above, . NR 1 R", wherein R' and R" represent, independently from each other,

H, an alkyl group, an alkenyl group, an alkynyl group, or an aryl group, as defined above,

. CONR'R", wherein R' and R" are as defined above, . NHCOR, wherein R is as defined above, . COOR, wherein R is as defined above,

. OCOR, wherein R is as defined above,

. OR, wherein R is as defined above,

. SR, wherein R is as defined above,

. SO 2 R, wherein R is as defined above,

. SO 2 NR 1 R", wherein R' and R" are as defined above,

. SO 3 H,

. halogen such as Cl, F, Br or I,

- CF 3 ,

. CN, and

. nitro, with the proviso that when Ri is H, then R 2 is not H, and that when R 2 is

H, then Ri is not H, and with the proviso that when Ri is OH, then R 2 is not OH, and that when

R 2 is OH, then R 1 is not OH.

Thus the compounds having the formula (II) wherein Ri = R 2 = H and Ri = R 2 = OH are excluded from the present invention.

The preferred intermediate compounds are chosen among the following:

The present invention also relates to the use of the above-mentioned compounds of formula (I), as a chromophore or as a semi-conductive material.

More particularly, the non-protonated compounds are preferably used as chromophores, and the protonated compounds are preferably used as semi-conductive materials.

The compounds of the invention can be used as electron donors.

The present invention also relates to the use of a compound of formula (I) as mentioned above, wherein at least one of Ri, R2, R3, and R 4 groups is COOH, as a light-emitting molecule.

The present invention also relates to the use of a compound of formula (I) as mentioned above, as a dye or pigment.

The present invention also relates to a cosmetic composition comprising a compound of formula (I) as mentioned above, in association with a cosmetically acceptable vehicle.

The expression "cosmetically acceptable vehicle" refers to a vehicle adapted for a use in contact with animal and human cells, in particular epidermal cells, without any toxicity, irritation, nor undue and similar allergic response.

The present invention also relates to method for the cosmetic treatment, comprising the administration of a compound of formula (I) as mentioned above, or of the cosmetic composition as mentioned above.

EXAMPLES

The commercially available 2,5-dihydroxy-p-benzoquinone reacted smoothly with various substituted o-diaminobenzenes (compounds of formula (IV)) 7-11 (1.1 equiv) in water (or alcohol) at 80O under ai r to afford high yields of new substituted dihydroxyphenazines 13-16 (intermediate compounds of formula (II)) which were fully characterized (Scheme 1 ).

7 R 1 = R 2 = H 12 R 1 = R 2 = H

8 R 1 = R 2 = Cl 13 R 1 = R 2 = Cl

9 R 1 = H , R 2 = Cl 14 R 1 = H , R 2 = Cl

10 R 1 = H , R 2 = COOH 15 R 1 = H , R 2 = COOH

11 R 1 = R 2 = CH, 16 R 1 = R 2 = CH 3

Scheme 1. Synthesis of DHTAP 18-23: (/) H 2 O or EtOH, 80O, 24h. (//) : catalytic amount of AcOH, 100O, 24h.

The phenazine intermediates 12-16 are then heated in presence of a catalytic amount (few drops) of glacial acetic acid and a large excess of N- substituted o-diaminobenzenes (compounds of formula (III)) (5 - 10 equiv) for 24 hrs (solvent free synthesis) affording substituted DHTAP derivatives 18-23 (compounds of formula (I)) as dark purple solids.

DETAILED PREPARATION OF THE COMPOUNDS OF THE INVENTION

/ - PREPARATION OF 2,3-DIHYDROXY-PHENAZINES

Method for the preparation of analogues of 2,3-dihydroxy- phenazine

A mixture of o-diaminobenzene (or analogue) (1 eq.) and of 2,5- dihydroxy-p-benzoquinone (1.1 to 2 eq.) in water or absolute ethanol is heated to reflux (1 h30 to 24h). The end of the reaction is controlled by TLC (eluent: ethyl acetate). The reaction mixture is concentrated under reduced pressure. The crude residue is taken up in an organic solvent and the insoluble part is filtered on sintered glass. The number of equivalents of 2,5- dihydroxy-p-benzoquinone, the volume of ethanol, the reaction time and the precipitation solvent are indicated below for each compound.

The compounds are further characterized with 1 H and 13 C NMR, MS and EA.

1- Synthesis of 2,3-dihydroxy-phenazine:

Protocol 1:

The reaction involves 500 mg (4.62 mmol; 1 eq) of o-diaminobenzene, 1.3 g (9.32 mmol, 2 eq) of 2,5-dihydroxy-p-benzoquinone in 500 mL of ethanol. The mixture is heated to reflux for 1 h30. The crude residue is then taken up in 20 mL of THF.

The desired compound is obtained as a brown solid and is obtained quantitatively.

Protocol 2:

The reaction involves 250 mg (2.31 mmol; 1 eq) of o-diaminobenzene, 356.25 mg (2.54 mmol; 1.1 eq) of 2,5-dihydroxy-p-benzoquinone in 250 ml_ of ethanol. The mixture is heated to reflux for 24h. The crude residue is taken up in 10 mL of THF.

The desired compound is obtained as a brown solid, with a yield of 93%.

1 H NMR (DMSO d 6 , ppm): 7.19 (s; 2H; H(1 ) and H(4)); 7.70 (dd; 2H; J 1 = 6.5 Hz, J 2 = 3.5 Hz; H(7) and H(8)); 8.02 (dd; 2H; J 1 = 6.5 Hz, J 2 = 3.5 Hz; H(6) and H(9)).

13 C NMR (DMSO d 6 , ppm): 106.49 (CH(1 ) and CH(4)); 127.56 (CH(6) and CH(9)); 128.31 (CH(7) and CH(8)); 141.55 (4 C ιv -N); 181.27 (C(2) and C(3)).

MS: [M-H + ] = 211

EA: C = 67.16; H = 3.87; N = 13.04 (Ci 2 H 8 N 2 O 2 . 1/9 EtOH: C = 67.55; H = 4.02; N = 12.89)

2- Synthesis of 2,3-dihydroxy-7,8-dichlorophenazine:

The reaction involves 300.7 mg (1.70 mmol; 1 eq.) of 1 ,2-diamino-4,5- dichlorobenzene, 262 mg (1.87 mmol; 1.1 eq.) of 2,5-dihydroxy-p- benzoquinone in 200 ml_ of ethanol. The mixture is then heated to reflux for

24h. The crude residue is taken up with a few ml_ of methanol. The insoluble part is rinsed with THF.

The desired compound is a brown solid and is obtained with a yield of 89%.

1 H NMR (DMSO d 6 , ppm): 7.23 (s; 2H; H (1 ) and H(4)); 8.30 (s; 2H; H(6) and H(9)); 11.30 (se; 2 OH).

MS: [M-H] + = 279

AE: Obtained values: C=50.8; H=2.3; N=10.3 (Theoretical values: C=51.27; H=2.15; N=9.97).

3- Synthesis of 2,3-dihydroxy-7-chlorophenazine:

The reaction is carried out with 200.7 mg (1.41 mmol; 1 eq.) of 1 ,2- diamino-4-chloro benzene and 216.6 mg (1.55 mmol; 1.1 eq.) of 2,5- dihydroxy-p-benzoquinone in 160 ml_ of ethanol. The mixture is then heated to reflux for 24h. The crude residue is taken up in a few ml_ (5-10 ml_) of ethanol.

The desired compound is a brown solid and is obtained with a yield of 90%.

1 H NMR (DMSO d 6 , ppm): 7.26 (se; 2H; H(1 ) and H(2)); 7.73 (dd; 1 H; J ortho = 9.25 Hz; J meta = 2.25 Hz; H(8)); 8.07 (d; 1 H; J ortho = 9.25 Hz; H(9)); 8.11 (se; 1 H; H(6)); 11.13 (se; 2H; 2 OH).

MS: [M+H] + = 247.7

4- Synthesis of 2,3-dihydroxy-phenazine-7-carboxylic acid:

d

The reaction involves 500 mg (3.28 mmol; 1 eq) of 1 ,2-diamino-4-acido benzene, 500 mg (3.57 mmol; 1.1 eq) of 2,5-dihydroxy-p-benzoquinone in 300 ml_ of ethanol. The mixture is then heated to reflux for 23h. The crude residue is taken up in 20 ml_ of THF.

The desired compound is a dark burgundy solid and is obtained with a yield of 77%.

1 H NMR (DMSO d 6 , ppm): 11 ,2 (se; 1 H; COOH); 8.59 (s; 1 H; H(6)); 8.16- 8.13 (m; 2H; H(8) and H(9)); 7.28 (se; 2H; H(1 ) and H(4)).

MS: [IvRH] + m/z = 257; [IvRNa] + m/z =279

AE : C=54.97; H=3.70; N=9.42 (Ci 3 H 8 N 2 O 4 .3/2 H 2 O: C=55.13; H=3.91 ; N=9.89).

5- Synthesis of 7,8-dimethyl-2,3-dihydroxy-phenazine:

The reaction is carried out with 175 mg (1.28 mmol; 1 eq) of 1 ,2- diamino-4,5-dimethyl benzene and 198 mg (1.41 mmol; 1.1 eq) of 2,5- dihydroxy-p-benzoquinone in 140 ml_ of ethanol. The mixture is heated to reflux for 24h. The crude residue is taken up in 7 ml_ of THF. The desired compound is a dark green solid and is obtained with a yield of 63%.

1 H RMN (DMSO d 6 , ppm): 10.80 (se; 2H; 2 OH) ; 7.79 (s; 2H; H(6) and H(9)); 7.22 (s; 2H; H(I ) and H(4)); 2.46 (s; 6H; 2 CH3).

SM: [M+H] + m/z = 241 ; [M+Na] + m/z =263.

AE: C=66.13; H=5.86; N=10.00 (Ci 4 Hi 2 N 2 O 2 . 5/4 EtOH : C=66.54; H=6.60; N=9.41 ).

// - PREPARATION OF DISSYMMETRICAL TETRAAZAPENTACENES

General method for the preparation of dissymmetrical analogues of tetraazapentacene

In a mortar, 1 eq of the intermediate 2,3-dihydroxy phenazine and 10 eq of an analogue of o-diaminobenzene are ground. The powder is transferred in a tube and glacial acetic acid is added (0.1 mL/0.1 mmol of the intermediate compound). The paste is heated at 100°C for 24h.

The volume of acetic acid, the conditions for the purification, the yield of the reaction as well as the details of the analyses are indicated below for each prepared compound.

The reaction involves 831 mg (3.92 mmol; 1 eq) of 2,3-dihydroxy phenazine, 4.23 g (39.16 mmol; 10 eq) of o-diaminobenzene and 4 ml_ of glacial acetic acid. The reaction residue is taken up in dichloromethane, filtered on sintered glass, rinsed with dichloromethane and then with methanol until obtaining colourless mother liquors. The desired compound is a violet solid and is obtained with a yield of 83%.

1 H NMR (DMSO d 6 , ppm): 9.70 (s; 2H; 2 NH); 7.68-7.40 (m; 4H; CH (8), (9), (10) and (11 )); 6.62-6.47 (m; 4H; CH(1 ), (2), (3) and (4)); 6.32 (s; 2H; CH (6) and (13)).

1 H 5 13 C NMR CPMAS (10 kHz): 147.1 and 145.7 (C (21 ) et (22)); 140.4 (C (18), (17), (20) and (19)); 129.7 (C (15) and (16)); 126.1 (CH (8), (9), (10) and (11 )); 124.2; 122.8 (CH (3)); 120.7 (CH (2)); 114.5 (CH (1 ) and (4)); 99.5 and 99.0 (CH (6) and (13)).

1 L HJ 5 1 1 3X NMR CPPI (C 5 CH 3 ): 147.1 ; 145.7; 140.4 and 129.7 (C).

MS: [M+H]+ = 285

EA: C = 74.21 ; N = 19.03; H = 4.13; Ci 8 Hi 2 N 4 .1/3: C = 74.47; H = 4.4; N 19.30).

lid

The reaction involves 200.6 mg (0.714 mmol; 1 eq) of 7,8-dichloro-2,3- dihydroxy phenazine, 771.5 mg (7.14 mmol; 10 eq) of o-diaminobenzene and 0.7 ml_ of glacial acetic acid. The reaction residue is taken up in dichloromethane, filtered on sintered glass, rinsed with dichloromethane and

then with methanol until obtaining colourless mother liquors. The desired compound is a violet solid and is obtained with a yield of 72%.

EA: C = 59.5; H = 2.7; N = 15.6; Ci 8 H 10 CI 2 N 4 . 1 / 2 H 2 O: C = 59.69 ; H = 3.06; N = 15.47.

lid

The reaction involves 150 mg (0.608 mmol; 1 eq) of 7-chloro-2,3- dihydroxy phenazine, 659.6 mg (6.10 mmol; 10 eq) of o-diaminobenzene and 0.6 ml_ of glacial acetic acid. The reaction residue is taken up in dichloromethane, filtered on sintered glass, rinsed with dichloromethane and then with methanol until obtaining colourless mother liquors. The desired compound is a violet solid and is obtained with a yield of 51 %.

MS: [IvRH] + = 319.2; [M-H] + = 317.2

EA: C = 65.3; H = 3.5; N = 16.6; Ci 8 H 11 CIN 4 . 1 / 2 H 2 O: C = 65.96 ; H = 3.69; N = 17.09.

lid

The reaction involves 201 mg (0.785 mmol; 1 eq) of 7-carboxy-2,3- dihydroxy phenazine, 848.4 mg (7.845 mmol; 10 eq) of o-diaminobenzene and 0.8 ml_ of glacial acetic acid. The reaction residue is taken up in dichloromethane, filtered on sintered glass, rinsed with dichloromethane and then with methanol until obtaining colourless mother liquors. The desired compound is a dark green solid and is obtained with a yield of 79%.

1 H NMR (DMSO d 6 , ppm): 10.08 (s; 1 H; NH (5)); 9.85 (s; 1 H; NH (14)); 7.72- 7.45 (m; 4H; H (8), (9), (10) and (11 )); 7.21 (d; 1 H; J = 8.25 Hz; H(2)); 7.04 (s; 1 H; H(4)); 6.51 (d; 1 H; J = 8.25 Hz; H(I )); 6.44 (s; 1 H; H(6)); 6.36 (s; 1 H; H(13)).

The reaction involves 200 mg (0.943 mmol; 1 eq) of 2,3-dihydroxy phenazine, 1.15 g (9.425 mmol; 10 eq) of 4-methyl-1 ,2diaminobenzene and 1 ml_ of glacial acetic acid. The reaction residue is taken up in dichloromethane, filtered on sintered glass, rinsed with dichloromethane and then with methanol until obtaining colourless mother liquors. The desired compound is a black solid and is obtained with a yield of 69%.

1 H 5 13 C NMR CPMAS (10 kHz): 146.0 (C (21 ) and (22)); 140.3 (C (17), (18), (19) and (20)); 135.5 (C (9)); 130.0 (C (15) et (16)); 126.2 (CH (8), (10) et (11 )); 120.9 (CH (2) and (3)); 114.4 (CH (3) and (4)); 99.8 (CH (6) and (13)); 22.8 (CH3).

1 L HJ, 1 I 3 J C NMR CPPI (C, CH3): 146.0; 140.3; 135.5 and 130.0 (C); 22.8 (CH3).

The reaction involves 100 mg (0.416 mmol; 1 eq) of 7,8-dimethyl-2,3- dihydroxy phenazine, 451 mg (4.170 mmol; 10 eq) of o-diaminobenzene and 0.4 ml_ of glacial acetic acid. The reaction residue is taken up in dichloromethane, filtered on sintered glass, rinsed with dichloromethane and then with methanol until obtaining colourless mother liquors. The desired compound is a black solid and is obtained with a yield of 70%.

1 H- 13 C NMR CPMAS (10 kHz): 146.6 and 145.0 (C (21 ) and (22)); 139.4 (C (17), (18), (19) and (20)); 135.8 (C (9) and (10)); 130.5 (C (15) and (16)); 125.2 (CH (8) and (11 )); 121.5 (CH (2) and (3)); 113.8 (CH (1 ) and (4)); 99.7 (CH(6) and (13)); 21.5 and 17.7 (2 CH 3 ).

1 H- 13 C NMR CPPI (C, CH3): 146.6; 145.0; 139.4; 135.8 and 130.5 (C); 21.5 and 17.7 (2 CH 3 ).

MS: [IvRH] + = 312.8

EA: C = 73.33; H = 5.15; N = 16.64; C 20 Hi 6 N 4 -H 2 O: C = 72.71 ; H = 5.49; N = 16.96.

The reaction involves 100 mg (0.390 mmol; 1 eq) of 7-carboxy-2,3- dihydroxy phenazine, 531.6 mg (3.903 mmol; 10 eq) of 4,5-dimethyl-1 ,2- diamino benzene and 0.4 ml_ of glacial acetic acid. The reaction residue is taken up in dichloromethane, filtered on sintered glass, rinsed with dichloromethane and then with methanol until obtaining colourless mother liquors. The desired compound is a black solid and is obtained with a yield of 70%.

1 H NMR (DMSO d 6 , ppm): 12.36 (se; 1 H; COOH); 9.85 and 9.62 (2 s; 2 * 1 H; 2 NH); 7.47 (se; 2H; H(8) and (11 )); 7.17 (dd; 1 H; H(3)); 6.98 (d; 1 H; H(I )); 6.46 (d; 1 H; H(4)); 6.38 (s; 1 H; H(6)); 6.31 (s; 1 H; H(13)); 2.35 (s; 6H; 2 CH 3 ).

MS: [IvRH] + = 357.8

PROPERTIES OF THE COMPOUNDS OF THE INVENTION

The conjugated pi-system of the pentacyclic core of the substituted DHTAPs of the invention rearranges depending on the electronic effect of the substituent(s).

The compounds of the invention can be used in photovoltaic or organic solar cells as the method of the invention allows the introduction of grafting groups, such as systems of Graetzel type. Such non-protonated compounds of the invention have the following absorption properties (in solution): from 450 to 600 nm (ε = 40 000-60 000

L.mol "1 .cm "1 ).

Such non-protonated compounds of the invention have the following absorption properties (in thin film): from 450 to 670 nm. Such protonated compounds of the invention have the following absorption properties (in solution): from 450 to 700 nm.

The compounds of the invention can be used in organic light emitting diodes (OLED) as the method of the invention allows the introduction of grafting groups, such as hybrid systems.

Such non-protonated compounds of the invention have the following absorption properties in solution: from 450 to 600 nm (ε = 40 000-60 000 L.mol "1 .cm "1 ). Such non-protonated compounds of the invention have the following fluorescence properties (in solution): from 550 to 700 nm.

Such non-protonated compounds of the invention have the following absorption properties (in solution): from 450 to 700 nm.

Such protonated compounds of the invention have the following fluorescence properties (in solution): from 650 to 750 nm.